Trials / Unknown
UnknownNCT02690129
Vaginal Progesterone for Treatment of Threatened Miscarriage
Vaginal Progesterone for Treatment of Threatened Miscarriage; Randomized Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 290 (estimated)
- Sponsor
- Omar Mamdouh Shaaban · Academic / Other
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the efficacy of vaginal micronized progesterone in the treatment of threatened miscarriage. All eligible pregnant women will be randomized to either receive vaginal progesterone or no treatment.Evaluation will be two weeks after intervention, then every 4 weeks up to 28 weeks gestation or termination of pregnancy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vaginal Progesteron |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-02-01
- Completion
- 2018-02-01
- First posted
- 2016-02-24
- Last updated
- 2016-02-24
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02690129. Inclusion in this directory is not an endorsement.